SCHEMBL13638420

SCHEMBL13638420

C=C1CC(Nc2nccc(-c3ccc(-c4ccccn4)s3)n2)CC(C)(C)N1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.38
NPC1 O15118 2/20 0.38
GLA P06280 2/20 0.38
MAPT P10636 2/20 0.38
RAB9A P51151 2/20 0.38
CDK1 P06493 5/20 0.35
CCNB1 P14635 5/20 0.35
CDK4 P11802 4/20 0.35
CCND1 P24385 4/20 0.35
CCNA2 P20248 4/20 0.35
CDK2 P24941 4/20 0.35
CCNA1 P78396 4/20 0.35
FLT3 P36888 3/20 0.34
AXL P30530 3/20 0.34
TYRO3 Q06418 3/20 0.34
MERTK Q12866 3/20 0.34
GAS6 Q14393 2/20 0.34
GPR39 O43194 1/20 0.34
RET P07949 4/20 0.34
IRAK4 Q9NWZ3 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14612854 0.88 IKBKB (0.42) CDK1CCNB1CDK4CCND1CCNA2
SCHEMBL13638428 0.86 CDK4 (0.42) KDM4ENPC1GLARAB9ACDK1
SCHEMBL13638501 0.86 HDAC8 (0.41) CDK1CCNB1CCNA2CDK2CCNA1
SCHEMBL13638286 0.86 ROCK2 (0.35) CDK1CCNB1CDK4CCND1CCNA2
SCHEMBL13638454 0.86 CDK4 (0.36) CDK1CCNB1CDK4CCND1CCNA2
SCHEMBL14612785 0.86 IKBKB (0.37) MAPTCDK1CCNB1CDK4CCND1
SCHEMBL3477653 0.85 KCNH2 (0.43) KDM4ENPC1GLAMAPTRAB9A
SCHEMBL14612805 0.85 APP (0.39) CDK1CCNB1CDK4CCND1CCNA2
SCHEMBL14612849 0.84 IKBKB (0.35) CDK1CCNB1CDK4CCND1CCNA2
SCHEMBL13638302 0.84 IKBKB (0.46) CDK1CCNB1CDK4CCND1CCNA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7615562-B2 Such as 2-methyl-4-{5-[2-(2,2,6,6-tetramethyl-piperidin-4-ylamino)-pyrimidin-4-yl]-thiophen-2-yl}-butan-2-ol; tumor necrosis factor inhibitors; immunosuppressants; antiinflammatory agents NOVARTIS AG (CH) 2009-11-10 US disclosed